Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

News Release

 View printer-friendly version

Charles River Laboratories Announces Departure of Dennis Shaughnessy, General Counsel
    
      Jody Acford to Join Charles River as Corporate Senior Vice
          President, General Counsel and Corporate Secretary

WILMINGTON, Mass.--(BUSINESS WIRE)--Dec. 1, 2004-- Charles River Laboratories International, Inc. (NYSE:CRL) announced today that Dennis Shaughnessy, Senior Vice President, Corporate Development, General Counsel and Secretary is leaving the Company effective December 31, 2004. Mr. Shaughnessy is joining the faculty of Northeastern University's College of Business Administration, where he will teach technology management, new ventures, strategic entrepreneurship, and intellectual property. He will continue to work with Charles River on a consulting basis, focusing on the development of in vitro drug discovery technologies and business models.

James C. Foster, Chairman, President and Chief Executive Officer of Charles River stated, "Dennis has made meaningful contributions to Charles River and has been instrumental in helping to position the Company for the future. His legal and business acumen has been critical through 23 acquisitions, a leveraged buy out and our initial public offering."

Assuming the responsibilities of Corporate Senior Vice President, General Counsel and Corporate Secretary for Charles River Laboratories will be Jody Acford. Ms. Acford joins Charles River from John Hancock Financial Services where she served as Senior Vice President and Deputy General Counsel. In this position, Ms. Acford was responsible for the legal activities relating to mergers, acquisitions, dispositions and joint ventures as well as investment initiatives and development of new products and markets.

At Charles River, Ms. Acford's key responsibilities will include providing advice to the Company with respect to legal activities involving acquisitions, joint ventures, governance, property and general corporate and commercial matters.

About Charles River Laboratories

Charles River Laboratories (CRL), based in Wilmington, Massachusetts, is a global provider of solutions that advance the drug discovery and development process. Our leading-edge products and services are designed to enable our clients to bring drugs to market faster and more efficiently. Backed by our rigorous, best-in-class procedures and our proven data collection, analysis and reporting capabilities, our products and services are organized into three categories spanning every step of the drug development pipeline: Research Models and Services, Pre-Clinical Services, and Clinical Services. CRL's customer base includes all of the major pharmaceutical companies, biotechnology companies, government agencies and many leading hospitals and academic institutions. Charles River's 8,000 employees serve clients in more than 50 countries. For more information on CRL, visit our website at www.criver.com.


    CONTACT: Charles River Laboratories International, Inc.
             Elizabeth Ferber, 978-658-6000 ext. 1693
             Director, Corporate Communications
             corpcomm@criver.com

    SOURCE: Charles River Laboratories International, Inc.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)